PUBLICATION
Engineering & Mining Journal
Mongolia Mining 2011 E&MJ Release
July 22, 2010
Mining in Mongolia is nothing new, but after years of being overlooked the spotlight is now on this vast country’s reserves. Mongolia’s mineral resources include gold, coal, copper, molybdenum, tin, tungsten and uranium. To date coal, copper and gold are the commodities, which have attracted the largest investments. Laurenz Melchers and Jim Dwyer, who heads the Business Council of Mongolia, defend Mongolia, despite the risk, as a good mining investment destination. They point to the reformed tax regime, the presence of major multinationals such as Rio Tinto, increased stability and an improving economic framework.
RELATED INTERVIEWS MORE INTERVIEWS
Tembo Power is developing hydropower projects across Africa with a focus on DRC.
Chesser Resources is upbeat about its Diamba Sud gold resource in Eastern Senegal.
Robocon speaks with GBR about the outlook for its services in Peru.
After cementing its position as a logistics industry leader in the DRC for over six decades, Comexas Afrique is launching into a new phase of existence and undergoing a rebrand, which will introduce the world to a new name, ConnexAfrica.
RELATED ARTICLES MORE ARTICLES
B.C. Mining Enters an Era of Reconciliation
British Columbia Mining 2019 Pre-Release Edition
True cohesion between government, Indigenous groups and the sector is the priority.
The Global Tailings Standard
The mining industry and investment community are collaborating to mitigate a perpetual risk, after a series of high-profile disasters.
RECENTLY PUBLISHED
United States Life Sciences 2023
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
MORE PREVIOUSLY PUBLISHED
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
MORE PREVIOUSLY PUBLISHED
MACIG
"With mining companies currently enjoying high prices, exceptional production performance and robust supply chains, we anticipate that the sector will continue showing resilience and growth, remaining financially sound in 2023."
SUBSCRIBE TO OUR NEWSLETTER
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
